{"gene":"KCTD8","run_date":"2026-04-28T18:30:27","timeline":{"discoveries":[{"year":2011,"finding":"KCTD8 was identified as an auxiliary subunit of GABAB receptors that associates with the receptor complex, influences biophysical and pharmacological properties of the receptor response, and generates largely non-desensitizing receptor responses. Distinct axonal or dendritic subcellular localizations were observed for individual KCTD proteins in neuronal populations.","method":"In situ hybridization, immunohistochemistry, biochemical co-assembly data","journal":"The Journal of comparative neurology","confidence":"Medium","confidence_rationale":"Tier 2-3 — multiple methods (ISH, IHC, biochemistry) from a single lab establishing subcellular localization and functional categorization","pmids":["21452234"],"is_preprint":false},{"year":2012,"finding":"KCTD8 generates non-desensitizing GABAB receptor responses. The T1 domain of KCTD8 binds to GABAB2. KCTD8 contains an H2 homology domain (absent in KCTD12/12b) that sterically inhibits desensitization in a sequence-independent manner. The H1 domain of KCTD8 lacks the T/NFLEQ motif responsible for desensitization in KCTD12/12b.","method":"Domain deletion/chimera mutagenesis, electrophysiological recordings in transfected cells, evolutionary sequence analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — active-site/domain mutagenesis combined with functional electrophysiology, multiple orthogonal approaches in one study","pmids":["23035119"],"is_preprint":false},{"year":2014,"finding":"KCTD8 slightly but significantly increases GABA affinity at recombinant GABAB receptors. KCTD8 also reduces tonic G-protein activation when co-expressed with GABAB receptors, leading to a larger increase in efficacy by the positive allosteric modulator GS39783 compared to receptors lacking KCTDs.","method":"[35S]GTPγS binding assay, BRET between G-protein subunits, Kir3 current recordings in transfected CHO cells and hippocampal neurons","journal":"Neuropharmacology","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal assays (GTPγS, BRET, electrophysiology) in a single study establishing pharmacological mechanism","pmids":["25196734"],"is_preprint":false},{"year":2016,"finding":"KCTD8 hetero-oligomerizes with other KCTD subunits (KCTD12, KCTD16) through self-interacting T1 and H1 homology domains. KCTD8-containing hetero-oligomers associate with both the GABAB receptor and the G-protein, expanding the functional repertoire of native GABAB receptors.","method":"Coimmunoprecipitation, BRET in live cells, electrophysiology in heterologous cells and KCTD knock-out mouse hippocampal neurons","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 1-2 — reciprocal CoIP, live-cell BRET, and electrophysiology in KO mice; multiple orthogonal methods","pmids":["28003345"],"is_preprint":false},{"year":2021,"finding":"KCTD8 directly binds to R-type Ca2+ channels (Cav2.3) in heterologous cells and potentiates Cav2.3 currents independently of GABAB receptor activation. In the rostral IPN, KCTD8 co-localizes with KCTD12b and Cav2.3 at the presynaptic active zone, and genetic deletion of KCTD8 modulates Cav2.3-mediated transmitter release, revealing a GABAB receptor-independent function.","method":"Heterologous cell expression with electrophysiology (Cav2.3 current recordings), co-localization by immunofluorescence, genetic deletion mouse models","journal":"eLife","confidence":"High","confidence_rationale":"Tier 1-2 — direct binding shown in heterologous system with functional current recordings plus in vivo genetic deletion with defined synaptic phenotype","pmids":["33913808"],"is_preprint":false},{"year":2022,"finding":"KCTD8 (together with KCTD12) facilitates axonal expression of GABAB receptors in habenula cholinergic neurons and thereby promotes presynaptic excitation (potentiation of glutamate release and Ca2+ entry) by GABAB receptors. Overexpressing KCTD8 in KCTD8/12/16 triple knock-out mice rescued axonal GABAB expression and presynaptic excitation, demonstrating an isoform-specific role.","method":"Multiple KCTD isoform-specific knock-out mouse lines, electrophysiology (glutamate release, presynaptic Ca2+ measurements), immunofluorescence of axonal vs. somatic GABAB expression, viral overexpression rescue experiments","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 — genetic KO with defined cellular phenotype, isoform specificity established by combinatorial KO analysis and rescue, replicated across multiple experimental approaches","pmids":["35017224"],"is_preprint":false},{"year":2023,"finding":"KCTD8 forms hetero-oligomeric complexes with KCTD5 (and other KCTD family members), with different regions on KCTD5 contributing to interactions with distinct KCTD partners including KCTD8.","method":"Co-immunoprecipitation in lysed cells, live-cell BRET, IP-luminescence domain mapping","journal":"International journal of molecular sciences","confidence":"Medium","confidence_rationale":"Tier 3 — CoIP and BRET showing interaction, but study is primarily focused on KCTD5 and mechanistic detail for KCTD8 specifically is limited","pmids":["37762619"],"is_preprint":false},{"year":2024,"finding":"KCTD8 suppresses hepatocellular carcinoma cell growth in vitro and in vivo by inhibiting the PI3K/AKT signaling pathway. KCTD8 expression is regulated by promoter DNA methylation in HCC.","method":"Flow cytometry, immunoprecipitation, xenograft mouse models, methylation-specific PCR","journal":"Epigenomics","confidence":"Medium","confidence_rationale":"Tier 2-3 — in vitro and in vivo functional assays with pathway readout (PI3K/AKT), but limited mechanistic detail on how KCTD8 inhibits the pathway","pmids":["39023358"],"is_preprint":false}],"current_model":"KCTD8 is an auxiliary subunit of GABAB receptors that associates with the receptor complex via its T1 domain binding to GABAB2 and generates non-desensitizing G-protein-coupled receptor responses through its H2 domain sterically blocking H1-mediated desensitization; it also directly binds and potentiates Cav2.3 Ca2+ channels independently of GABAB receptors, facilitates axonal trafficking of GABAB receptors in habenula cholinergic neurons to enable presynaptic excitation, can form hetero-oligomers with other KCTD family members through T1 and H1 domains, and suppresses PI3K/AKT signaling to inhibit hepatocellular carcinoma growth."},"narrative":{"teleology":[{"year":2011,"claim":"Establishing KCTD8 as a GABAB receptor auxiliary subunit resolved how subunit-specific properties such as non-desensitizing responses and distinct subcellular localization arise in native receptor complexes.","evidence":"In situ hybridization, immunohistochemistry, and biochemical co-assembly in brain tissue and heterologous cells","pmids":["21452234"],"confidence":"Medium","gaps":["Molecular domains mediating receptor binding and desensitization control were undefined","Pharmacological consequences of KCTD8 association were not quantified","Single-lab study without independent replication at this stage"]},{"year":2012,"claim":"Mapping the domain architecture of KCTD8 revealed that the T1 domain mediates GABAB2 binding and an H2 domain unique to KCTD8/16 sterically prevents H1-mediated desensitization, explaining how KCTD8 generates non-desensitizing responses.","evidence":"Domain deletion/chimera mutagenesis combined with electrophysiological recordings in transfected cells","pmids":["23035119"],"confidence":"High","gaps":["Structural basis for H2-mediated steric inhibition was not resolved","Whether the same mechanism operates at native synapses was untested"]},{"year":2014,"claim":"Quantifying KCTD8's pharmacological effects showed it increases GABA affinity and reduces tonic G-protein activation, explaining enhanced positive allosteric modulator efficacy at KCTD8-containing receptors.","evidence":"[35S]GTPγS binding, BRET between G-protein subunits, and Kir3 current recordings in CHO cells and hippocampal neurons","pmids":["25196734"],"confidence":"High","gaps":["Mechanism by which KCTD8 reduces tonic G-protein activation was not identified","In vivo pharmacological relevance was not tested"]},{"year":2016,"claim":"Demonstrating that KCTD8 hetero-oligomerizes with KCTD12 and KCTD16 through T1 and H1 domains established that combinatorial KCTD assembly diversifies native GABAB receptor properties.","evidence":"Reciprocal co-immunoprecipitation, live-cell BRET, and electrophysiology in KCTD knock-out mouse hippocampal neurons","pmids":["28003345"],"confidence":"High","gaps":["Stoichiometry of hetero-oligomeric complexes was not determined","Functional consequences of specific hetero-oligomer combinations in defined circuits were unknown"]},{"year":2021,"claim":"Discovering that KCTD8 directly binds and potentiates Cav2.3 channels independently of GABAB receptors revealed a receptor-independent ion channel regulatory function at presynaptic terminals.","evidence":"Heterologous cell Cav2.3 current recordings, immunofluorescence co-localization in rostral IPN, and KCTD8 genetic deletion mouse models with transmitter release assays","pmids":["33913808"],"confidence":"High","gaps":["Binding interface between KCTD8 and Cav2.3 was not mapped","Whether KCTD8 modulates other Cav channel subtypes was untested"]},{"year":2022,"claim":"Showing that KCTD8 facilitates axonal trafficking of GABAB receptors in habenula cholinergic neurons explained how KCTD isoforms control the subcellular compartmentalization of receptor signaling and enable presynaptic excitation.","evidence":"Combinatorial KCTD isoform knock-out mice, electrophysiology of glutamate release and presynaptic Ca2+, viral KCTD8 overexpression rescue in triple-KO animals","pmids":["35017224"],"confidence":"High","gaps":["Molecular mechanism of axonal trafficking promotion (motor adaptors, sorting signals) was not identified","Whether this trafficking role extends beyond habenula cholinergic neurons was unknown"]},{"year":2023,"claim":"Identification of KCTD8–KCTD5 hetero-oligomers broadened the interactome beyond the GABAB-associated KCTD clade, suggesting cross-family combinatorial assembly.","evidence":"Co-immunoprecipitation, live-cell BRET, and IP-luminescence domain mapping","pmids":["37762619"],"confidence":"Medium","gaps":["Functional consequence of KCTD8–KCTD5 interaction was not determined","Study focused primarily on KCTD5; reciprocal validation from KCTD8 perspective was limited","In vivo relevance of this interaction was not tested"]},{"year":2024,"claim":"Demonstrating that KCTD8 suppresses hepatocellular carcinoma growth via PI3K/AKT pathway inhibition revealed a non-neuronal tumor-suppressive role regulated by promoter methylation.","evidence":"Flow cytometry, immunoprecipitation, xenograft mouse models, and methylation-specific PCR in HCC cell lines","pmids":["39023358"],"confidence":"Medium","gaps":["Direct molecular target within PI3K/AKT pathway was not identified","Whether BTB-domain ubiquitin ligase activity underlies AKT suppression was not tested","Single study without independent replication"]},{"year":null,"claim":"The structural basis of KCTD8's H2 domain steric block, the molecular mechanism by which it promotes axonal receptor trafficking, the binding interface with Cav2.3, and the direct target in PI3K/AKT signaling remain unresolved.","evidence":"","pmids":[],"confidence":"High","gaps":["No high-resolution structure of KCTD8 or its complexes exists","Axonal trafficking mechanism (motor adaptors, sorting signals) is unknown","Direct molecular link between KCTD8 and PI3K/AKT pathway is uncharacterized"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[1,2,4]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,4,5]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[1,2,3,5]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[4,5]}],"complexes":["GABAB receptor complex"],"partners":["GABBR2","CACNA1E","KCTD12","KCTD16","KCTD5"],"other_free_text":[]},"mechanistic_narrative":"KCTD8 is an auxiliary subunit of GABAB receptors that shapes receptor signaling kinetics, subcellular trafficking, and downstream effector coupling in neurons. Its T1 domain binds GABAB2 to mediate receptor association, while a unique H2 domain sterically blocks H1-mediated desensitization, generating non-desensitizing GABAB receptor responses; KCTD8 also slightly increases GABA affinity and reduces tonic G-protein activation [PMID:23035119, PMID:25196734]. Beyond GABAB receptors, KCTD8 directly binds and potentiates Cav2.3 (R-type) calcium channels independently of GABAB signaling and facilitates axonal trafficking of GABAB receptors in habenula cholinergic neurons to enable presynaptic excitatory modulation [PMID:33913808, PMID:35017224]. KCTD8 hetero-oligomerizes with KCTD12, KCTD16, and KCTD5 through T1 and H1 domains, expanding the functional diversity of native receptor complexes, and additionally suppresses PI3K/AKT signaling to inhibit hepatocellular carcinoma growth [PMID:28003345, PMID:39023358]."},"prefetch_data":{"uniprot":{"accession":"Q6ZWB6","full_name":"BTB/POZ domain-containing protein KCTD8","aliases":[],"length_aa":473,"mass_kda":52.4,"function":"Auxiliary subunit of GABA-B receptors that determine the pharmacology and kinetics of the receptor response. Increases agonist potency and markedly alter the G-protein signaling of the receptors by accelerating onset and promoting desensitization (By similarity)","subcellular_location":"Presynaptic cell membrane; Postsynaptic cell membrane","url":"https://www.uniprot.org/uniprotkb/Q6ZWB6/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/KCTD8","classification":"Not Classified","n_dependent_lines":2,"n_total_lines":1208,"dependency_fraction":0.0016556291390728477},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/KCTD8","total_profiled":1310},"omim":[{"mim_id":"618442","title":"POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING PROTEIN 8; KCTD8","url":"https://www.omim.org/entry/618442"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Cytoplasmic bodies","reliability":"Approved"}],"tissue_specificity":"Group enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"brain","ntpm":16.9},{"tissue":"retina","ntpm":6.3}],"url":"https://www.proteinatlas.org/search/KCTD8"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"Q6ZWB6","domains":[{"cath_id":"3.30.710.10","chopping":"44-76_88-145","consensus_level":"high","plddt":89.8984,"start":44,"end":145},{"cath_id":"-","chopping":"206-220_228-320","consensus_level":"high","plddt":90.0219,"start":206,"end":320}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q6ZWB6","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q6ZWB6-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q6ZWB6-F1-predicted_aligned_error_v6.png","plddt_mean":66.0},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=KCTD8","jax_strain_url":"https://www.jax.org/strain/search?query=KCTD8"},"sequence":{"accession":"Q6ZWB6","fasta_url":"https://rest.uniprot.org/uniprotkb/Q6ZWB6.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q6ZWB6/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q6ZWB6"}},"corpus_meta":[{"pmid":"22930747","id":"PMC_22930747","title":"Genome-wide methylation screen in low-grade breast cancer identifies novel epigenetically altered genes as potential biomarkers for tumor diagnosis.","date":"2012","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/22930747","citation_count":77,"is_preprint":false},{"pmid":"21452234","id":"PMC_21452234","title":"Distribution of the auxiliary GABAB receptor subunits KCTD8, 12, 12b, and 16 in the mouse brain.","date":"2011","source":"The Journal of comparative neurology","url":"https://pubmed.ncbi.nlm.nih.gov/21452234","citation_count":73,"is_preprint":false},{"pmid":"28003345","id":"PMC_28003345","title":"KCTD Hetero-oligomers Confer Unique Kinetic Properties on Hippocampal GABAB Receptor-Induced K+ Currents.","date":"2016","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/28003345","citation_count":48,"is_preprint":false},{"pmid":"23035119","id":"PMC_23035119","title":"Opposite effects of KCTD subunit domains on GABA(B) receptor-mediated desensitization.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23035119","citation_count":47,"is_preprint":false},{"pmid":"25689571","id":"PMC_25689571","title":"Altered emotionality and neuronal excitability in mice lacking KCTD12, an auxiliary subunit of GABAB receptors associated with mood disorders.","date":"2015","source":"Translational psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/25689571","citation_count":43,"is_preprint":false},{"pmid":"23843457","id":"PMC_23843457","title":"Up-regulation of GABA(B) receptor signaling by constitutive assembly with the K+ channel tetramerization domain-containing protein 12 (KCTD12).","date":"2013","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23843457","citation_count":36,"is_preprint":false},{"pmid":"25196734","id":"PMC_25196734","title":"Pharmacological characterization of GABAB receptor subtypes assembled with auxiliary KCTD subunits.","date":"2014","source":"Neuropharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/25196734","citation_count":31,"is_preprint":false},{"pmid":"22156575","id":"PMC_22156575","title":"KCTD8 gene and brain growth in adverse intrauterine environment: a genome-wide association study.","date":"2011","source":"Cerebral cortex (New York, N.Y. : 1991)","url":"https://pubmed.ncbi.nlm.nih.gov/22156575","citation_count":30,"is_preprint":false},{"pmid":"23937595","id":"PMC_23937595","title":"A genome-wide search for type 2 diabetes susceptibility genes in an extended Arab family.","date":"2013","source":"Annals of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23937595","citation_count":27,"is_preprint":false},{"pmid":"33913808","id":"PMC_33913808","title":"GABAB receptor auxiliary subunits modulate Cav2.3-mediated release from medial habenula terminals.","date":"2021","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/33913808","citation_count":21,"is_preprint":false},{"pmid":"35017224","id":"PMC_35017224","title":"KCTD8 and KCTD12 Facilitate Axonal Expression of GABAB Receptors in Habenula Cholinergic Neurons.","date":"2022","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/35017224","citation_count":12,"is_preprint":false},{"pmid":"37762619","id":"PMC_37762619","title":"KCTD5 Forms Hetero-Oligomeric Complexes with Various Members of the KCTD Protein Family.","date":"2023","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/37762619","citation_count":11,"is_preprint":false},{"pmid":"37799139","id":"PMC_37799139","title":"Uncovering structural variants associated with body weight and obesity risk in labrador retrievers: a genome-wide study.","date":"2023","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/37799139","citation_count":4,"is_preprint":false},{"pmid":"39023358","id":"PMC_39023358","title":"Epigenetic silencing of KCTD8 promotes hepatocellular carcinoma growth by activating PI3K/AKT signaling.","date":"2024","source":"Epigenomics","url":"https://pubmed.ncbi.nlm.nih.gov/39023358","citation_count":1,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":9422,"output_tokens":2127,"usd":0.030086},"stage2":{"model":"claude-opus-4-6","input_tokens":5407,"output_tokens":2301,"usd":0.12684},"total_usd":0.156926,"stage1_batch_id":"msgbatch_01Mgbec4vM6c9vXht7JVJzss","stage2_batch_id":"msgbatch_01JkuuH5RB2BdJNsgnhjbC6s","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2011,\n      \"finding\": \"KCTD8 was identified as an auxiliary subunit of GABAB receptors that associates with the receptor complex, influences biophysical and pharmacological properties of the receptor response, and generates largely non-desensitizing receptor responses. Distinct axonal or dendritic subcellular localizations were observed for individual KCTD proteins in neuronal populations.\",\n      \"method\": \"In situ hybridization, immunohistochemistry, biochemical co-assembly data\",\n      \"journal\": \"The Journal of comparative neurology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — multiple methods (ISH, IHC, biochemistry) from a single lab establishing subcellular localization and functional categorization\",\n      \"pmids\": [\"21452234\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"KCTD8 generates non-desensitizing GABAB receptor responses. The T1 domain of KCTD8 binds to GABAB2. KCTD8 contains an H2 homology domain (absent in KCTD12/12b) that sterically inhibits desensitization in a sequence-independent manner. The H1 domain of KCTD8 lacks the T/NFLEQ motif responsible for desensitization in KCTD12/12b.\",\n      \"method\": \"Domain deletion/chimera mutagenesis, electrophysiological recordings in transfected cells, evolutionary sequence analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — active-site/domain mutagenesis combined with functional electrophysiology, multiple orthogonal approaches in one study\",\n      \"pmids\": [\"23035119\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"KCTD8 slightly but significantly increases GABA affinity at recombinant GABAB receptors. KCTD8 also reduces tonic G-protein activation when co-expressed with GABAB receptors, leading to a larger increase in efficacy by the positive allosteric modulator GS39783 compared to receptors lacking KCTDs.\",\n      \"method\": \"[35S]GTPγS binding assay, BRET between G-protein subunits, Kir3 current recordings in transfected CHO cells and hippocampal neurons\",\n      \"journal\": \"Neuropharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal assays (GTPγS, BRET, electrophysiology) in a single study establishing pharmacological mechanism\",\n      \"pmids\": [\"25196734\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"KCTD8 hetero-oligomerizes with other KCTD subunits (KCTD12, KCTD16) through self-interacting T1 and H1 homology domains. KCTD8-containing hetero-oligomers associate with both the GABAB receptor and the G-protein, expanding the functional repertoire of native GABAB receptors.\",\n      \"method\": \"Coimmunoprecipitation, BRET in live cells, electrophysiology in heterologous cells and KCTD knock-out mouse hippocampal neurons\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — reciprocal CoIP, live-cell BRET, and electrophysiology in KO mice; multiple orthogonal methods\",\n      \"pmids\": [\"28003345\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"KCTD8 directly binds to R-type Ca2+ channels (Cav2.3) in heterologous cells and potentiates Cav2.3 currents independently of GABAB receptor activation. In the rostral IPN, KCTD8 co-localizes with KCTD12b and Cav2.3 at the presynaptic active zone, and genetic deletion of KCTD8 modulates Cav2.3-mediated transmitter release, revealing a GABAB receptor-independent function.\",\n      \"method\": \"Heterologous cell expression with electrophysiology (Cav2.3 current recordings), co-localization by immunofluorescence, genetic deletion mouse models\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct binding shown in heterologous system with functional current recordings plus in vivo genetic deletion with defined synaptic phenotype\",\n      \"pmids\": [\"33913808\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"KCTD8 (together with KCTD12) facilitates axonal expression of GABAB receptors in habenula cholinergic neurons and thereby promotes presynaptic excitation (potentiation of glutamate release and Ca2+ entry) by GABAB receptors. Overexpressing KCTD8 in KCTD8/12/16 triple knock-out mice rescued axonal GABAB expression and presynaptic excitation, demonstrating an isoform-specific role.\",\n      \"method\": \"Multiple KCTD isoform-specific knock-out mouse lines, electrophysiology (glutamate release, presynaptic Ca2+ measurements), immunofluorescence of axonal vs. somatic GABAB expression, viral overexpression rescue experiments\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO with defined cellular phenotype, isoform specificity established by combinatorial KO analysis and rescue, replicated across multiple experimental approaches\",\n      \"pmids\": [\"35017224\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"KCTD8 forms hetero-oligomeric complexes with KCTD5 (and other KCTD family members), with different regions on KCTD5 contributing to interactions with distinct KCTD partners including KCTD8.\",\n      \"method\": \"Co-immunoprecipitation in lysed cells, live-cell BRET, IP-luminescence domain mapping\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — CoIP and BRET showing interaction, but study is primarily focused on KCTD5 and mechanistic detail for KCTD8 specifically is limited\",\n      \"pmids\": [\"37762619\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"KCTD8 suppresses hepatocellular carcinoma cell growth in vitro and in vivo by inhibiting the PI3K/AKT signaling pathway. KCTD8 expression is regulated by promoter DNA methylation in HCC.\",\n      \"method\": \"Flow cytometry, immunoprecipitation, xenograft mouse models, methylation-specific PCR\",\n      \"journal\": \"Epigenomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — in vitro and in vivo functional assays with pathway readout (PI3K/AKT), but limited mechanistic detail on how KCTD8 inhibits the pathway\",\n      \"pmids\": [\"39023358\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"KCTD8 is an auxiliary subunit of GABAB receptors that associates with the receptor complex via its T1 domain binding to GABAB2 and generates non-desensitizing G-protein-coupled receptor responses through its H2 domain sterically blocking H1-mediated desensitization; it also directly binds and potentiates Cav2.3 Ca2+ channels independently of GABAB receptors, facilitates axonal trafficking of GABAB receptors in habenula cholinergic neurons to enable presynaptic excitation, can form hetero-oligomers with other KCTD family members through T1 and H1 domains, and suppresses PI3K/AKT signaling to inhibit hepatocellular carcinoma growth.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"KCTD8 is an auxiliary subunit of GABAB receptors that shapes receptor signaling kinetics, subcellular trafficking, and downstream effector coupling in neurons. Its T1 domain binds GABAB2 to mediate receptor association, while a unique H2 domain sterically blocks H1-mediated desensitization, generating non-desensitizing GABAB receptor responses; KCTD8 also slightly increases GABA affinity and reduces tonic G-protein activation [PMID:23035119, PMID:25196734]. Beyond GABAB receptors, KCTD8 directly binds and potentiates Cav2.3 (R-type) calcium channels independently of GABAB signaling and facilitates axonal trafficking of GABAB receptors in habenula cholinergic neurons to enable presynaptic excitatory modulation [PMID:33913808, PMID:35017224]. KCTD8 hetero-oligomerizes with KCTD12, KCTD16, and KCTD5 through T1 and H1 domains, expanding the functional diversity of native receptor complexes, and additionally suppresses PI3K/AKT signaling to inhibit hepatocellular carcinoma growth [PMID:28003345, PMID:39023358].\",\n  \"teleology\": [\n    {\n      \"year\": 2011,\n      \"claim\": \"Establishing KCTD8 as a GABAB receptor auxiliary subunit resolved how subunit-specific properties such as non-desensitizing responses and distinct subcellular localization arise in native receptor complexes.\",\n      \"evidence\": \"In situ hybridization, immunohistochemistry, and biochemical co-assembly in brain tissue and heterologous cells\",\n      \"pmids\": [\"21452234\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Molecular domains mediating receptor binding and desensitization control were undefined\",\n        \"Pharmacological consequences of KCTD8 association were not quantified\",\n        \"Single-lab study without independent replication at this stage\"\n      ]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Mapping the domain architecture of KCTD8 revealed that the T1 domain mediates GABAB2 binding and an H2 domain unique to KCTD8/16 sterically prevents H1-mediated desensitization, explaining how KCTD8 generates non-desensitizing responses.\",\n      \"evidence\": \"Domain deletion/chimera mutagenesis combined with electrophysiological recordings in transfected cells\",\n      \"pmids\": [\"23035119\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Structural basis for H2-mediated steric inhibition was not resolved\",\n        \"Whether the same mechanism operates at native synapses was untested\"\n      ]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Quantifying KCTD8's pharmacological effects showed it increases GABA affinity and reduces tonic G-protein activation, explaining enhanced positive allosteric modulator efficacy at KCTD8-containing receptors.\",\n      \"evidence\": \"[35S]GTPγS binding, BRET between G-protein subunits, and Kir3 current recordings in CHO cells and hippocampal neurons\",\n      \"pmids\": [\"25196734\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Mechanism by which KCTD8 reduces tonic G-protein activation was not identified\",\n        \"In vivo pharmacological relevance was not tested\"\n      ]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Demonstrating that KCTD8 hetero-oligomerizes with KCTD12 and KCTD16 through T1 and H1 domains established that combinatorial KCTD assembly diversifies native GABAB receptor properties.\",\n      \"evidence\": \"Reciprocal co-immunoprecipitation, live-cell BRET, and electrophysiology in KCTD knock-out mouse hippocampal neurons\",\n      \"pmids\": [\"28003345\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Stoichiometry of hetero-oligomeric complexes was not determined\",\n        \"Functional consequences of specific hetero-oligomer combinations in defined circuits were unknown\"\n      ]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Discovering that KCTD8 directly binds and potentiates Cav2.3 channels independently of GABAB receptors revealed a receptor-independent ion channel regulatory function at presynaptic terminals.\",\n      \"evidence\": \"Heterologous cell Cav2.3 current recordings, immunofluorescence co-localization in rostral IPN, and KCTD8 genetic deletion mouse models with transmitter release assays\",\n      \"pmids\": [\"33913808\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Binding interface between KCTD8 and Cav2.3 was not mapped\",\n        \"Whether KCTD8 modulates other Cav channel subtypes was untested\"\n      ]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Showing that KCTD8 facilitates axonal trafficking of GABAB receptors in habenula cholinergic neurons explained how KCTD isoforms control the subcellular compartmentalization of receptor signaling and enable presynaptic excitation.\",\n      \"evidence\": \"Combinatorial KCTD isoform knock-out mice, electrophysiology of glutamate release and presynaptic Ca2+, viral KCTD8 overexpression rescue in triple-KO animals\",\n      \"pmids\": [\"35017224\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Molecular mechanism of axonal trafficking promotion (motor adaptors, sorting signals) was not identified\",\n        \"Whether this trafficking role extends beyond habenula cholinergic neurons was unknown\"\n      ]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Identification of KCTD8–KCTD5 hetero-oligomers broadened the interactome beyond the GABAB-associated KCTD clade, suggesting cross-family combinatorial assembly.\",\n      \"evidence\": \"Co-immunoprecipitation, live-cell BRET, and IP-luminescence domain mapping\",\n      \"pmids\": [\"37762619\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Functional consequence of KCTD8–KCTD5 interaction was not determined\",\n        \"Study focused primarily on KCTD5; reciprocal validation from KCTD8 perspective was limited\",\n        \"In vivo relevance of this interaction was not tested\"\n      ]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Demonstrating that KCTD8 suppresses hepatocellular carcinoma growth via PI3K/AKT pathway inhibition revealed a non-neuronal tumor-suppressive role regulated by promoter methylation.\",\n      \"evidence\": \"Flow cytometry, immunoprecipitation, xenograft mouse models, and methylation-specific PCR in HCC cell lines\",\n      \"pmids\": [\"39023358\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Direct molecular target within PI3K/AKT pathway was not identified\",\n        \"Whether BTB-domain ubiquitin ligase activity underlies AKT suppression was not tested\",\n        \"Single study without independent replication\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The structural basis of KCTD8's H2 domain steric block, the molecular mechanism by which it promotes axonal receptor trafficking, the binding interface with Cav2.3, and the direct target in PI3K/AKT signaling remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No high-resolution structure of KCTD8 or its complexes exists\",\n        \"Axonal trafficking mechanism (motor adaptors, sorting signals) is unknown\",\n        \"Direct molecular link between KCTD8 and PI3K/AKT pathway is uncharacterized\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [1, 2, 4]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 4, 5]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [1, 2, 3, 5]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [4, 5]}\n    ],\n    \"complexes\": [\n      \"GABAB receptor complex\"\n    ],\n    \"partners\": [\n      \"GABBR2\",\n      \"CACNA1E\",\n      \"KCTD12\",\n      \"KCTD16\",\n      \"KCTD5\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}